A common strategy to manage ergotamine-associated nausea is:

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Multiple Choice

A common strategy to manage ergotamine-associated nausea is:

Managing ergotamine-associated nausea is best done by pretreating with an antiemetic. Nausea is a common adverse effect of ergotamine, likely involving stimulation of the vomiting center and gut pathways. Giving an antiemetic before the dose helps prevent this nausea from developing, making the therapy more tolerable. Antiém etics such as metoclopramide, prochlorperazine, or ondansetron work by blocking receptors in the chemoreceptor trigger zone or by reducing gut-mediated signals, and some (like metoclopramide) also improve gastric emptying to aid absorption. Increasing the ergotamine dose would worsen nausea, and co-administering with caffeine is not aimed at antiemesis and can add others side effects; avoiding antiemetics leaves the patient with unmitigated nausea.

Managing ergotamine-associated nausea is best done by pretreating with an antiemetic. Nausea is a common adverse effect of ergotamine, likely involving stimulation of the vomiting center and gut pathways. Giving an antiemetic before the dose helps prevent this nausea from developing, making the therapy more tolerable. Antiém etics such as metoclopramide, prochlorperazine, or ondansetron work by blocking receptors in the chemoreceptor trigger zone or by reducing gut-mediated signals, and some (like metoclopramide) also improve gastric emptying to aid absorption. Increasing the ergotamine dose would worsen nausea, and co-administering with caffeine is not aimed at antiemesis and can add others side effects; avoiding antiemetics leaves the patient with unmitigated nausea.

More practice questions